• HOME
  •  > 
  • 薬学
  •  > 
  • 雑誌
  •  >  医学と薬学　80/10　2023年10月号

医学と薬学　80/10　2023年10月号

出版社： 自然科学社
発行日： 2023-09-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： 呼吸不全診療の進歩と最新の話題
電子書籍版： 2023-09-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,760 円(税込)

購入する

目次

  • 特集　呼吸不全診療の進歩と最新の話題

    序文
    呼吸不全の病態と診断―息切れ／呼吸困難から疑う疾患
    COVID-19肺炎による急性呼吸不全―11個のポイント
    睡眠呼吸障害と呼吸不全
    在宅酸素療法
    高流量鼻カニュラ酸素療法（HFNC）―急性期から慢性期まで
    横隔膜ペーシング

    Diagnosis
    　ルミパルス®L2400による全自動タクロリムス定量試薬
    　「ルミパルスプレスト® iTACT® タクロリムス」の基礎的検討

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 呼吸不全診療の進歩と最新の話題】

P.955 掲載の参考文献
1) 日本呼吸器学会 (編): 新呼吸器専門医テキスト 改訂第2版, 南江堂, 東京, 2020.
 
2) 矢崎義雄, 小室一成 (総編集): 内科学第12版, 朝倉書店, 東京, 2022.
 
3) Parshall MB, Schwartzstein RM, Adams L, et al : An official American Thoracic Society statement: update on the mechanisms, assessment, and man-agement of dyspnea. Am J Respir Crit Care Med 185 : 435-452, 2012.
 
4) Mullerova H, Lu C, Li H, et al : Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One 9 : e85540, 2014.
 
P.969 掲載の参考文献
1) Wang Y, Liu Y, Liu L, et al : Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China. J Infect Dis 221 : 1770, 2020.
 
2) Wu, Z, McGoogan JM : Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323 : 1239-1242, 2020.
 
3) Okudela K, Hayashi H, Yoshimura Y, et al : A Japanese case of COVID-19 : an autopsy report. Pathol Int 70 : 820-824, 2020.
PubMed
4) 厚生労働省 : 新型コロナウイルス感染症 (COVID-19) 診療の手引き 第10.0版, 2023.
 
5) Ferguson ND, Fan E, Camporota L, et al : The Berlin defnition of ARDS: an expanded rationale, justifcation, and supplementary material. Intensive Care Med 38 : 1573-1582, 2012.
 
6) Gattinoni L, Meissner K, Marini JJ : The baby lung and the COVID-19 era. Intensive Care Med 46 : 1438-1440, 2020.
PubMed
7) Fan E, Del Sorbo L, Goligher EC : An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respira-tory Distress Syndrome. Am J Respir Crit Care Med 195 : 1253-1263, 2017.
 
8) 則末泰博 : COVID-19による重症ARDS患者の管理. 小倉高志 (編): 別冊「呼吸器ジャーナル」COVID-19の病態・診断・治療 現場の知恵とこれからの羅針盤, pp.93-100, 医学書院, 2020.
 
9) Gattinoni L, Coppola S, Cressoni M, et al : COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 201 : 1299-1300, 2020.
PubMed
10) Gattinoni L, Chiumello D, Caironi P, et al : COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46 : 1099-1102, 2020.
PubMed
11) Camporota L, Vasques F, Sanderson B, et al : Identification of pathophysiological patterns for triage and respiratory support in COVID-19. Lancet Respir Med 8 : 752-754, 2020.
PubMed
12) Grasselli G, Tonetti T, Protti A, et al : Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicenter prospective observational study. Lancet Respir Med 8 : 1201-1208, 2020.
PubMed
13) Iwasawa T, Sato M, Yamaya T, et al : Ultra-high-resolution Computed Tomography Can Demonstrate Alveolar Collapse in Novel Corona-virus (COVID-19) Pneumonia. Jpn J Radiol 38 : 394-398, 2020.
 
14) Katsura H, Sontake V, Tata A, et al : Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction. Cell Stem Cell 27 : 890-904, 2020.
PubMed
15) Lang M, Som A, Carey D, et al : Pulmonary vascular manifestations of COVID-19 pneumonia. Radiol Cardiothorac imaging 2 : e2020200277, 2020.
PubMed
16) Aoki R, Iwasawa T, Hagiwara E, et al : Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity. Jpn J Radio 39 : 451-458, 2021.
 
17) 小倉高志, 岩澤多恵, 泉 信有, 他 : COVID-19の臨床と画像経過. 病理と臨床 39 : 1204-1215, 2021.
Medical*Online
18) 岩澤多恵 : COVID-19の画像診断-人工知能 (AI) を用いた自動診断やコンピュータによる定量評価. 小倉高志 (編): 別冊「呼吸器ジャーナル」COVID-19の病態・診断・治療 現場の知恵とこれからの羅針盤, pp.77-81, 医学書院, 2020.
 
19) Iwasawa T, Matsushita S, Hirayama M et al : Quantitative analysis for Lung Disease on Thin-Section CT. Diagnostics, 2023. [in press]
 
20) Calfee CS, Delucchi K, Parsons PE, et al : Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2 : 611-620, 2014.
PubMed
21) Sinha P, Calfee CS, Cherian S, et al : Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids. Am J Respir Crit Care Med 204 : 1274-1285, 2021.
 
22) Sinha P, Calfee CS, Cherian S, et al : Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19 : a prospective observational study. Lancet Respir Med 8 : 1209-1218, 2020.
PubMed
23) Grasselli G, Calfee CS, Camporota L, et al : ESICM guidelines on acute respiratory 134_2023_Article_7050ESICM guidelines on acute respiratory distress syndrome: defnition, phenotyping and respiratory support strategies Intensive Care Med 49: 727-759, 2023.
 
24) Ospina-Tascon GA, Calderon-Tapia LE, Garcia AF, et al : Efect of high-fow oxygen therapy vs conventional oxygen therapy on invasive mechan-ical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA 326 : 2161-2171, 2021.
 
25) Takazono T, Yamamoto K, Okamoto R, et al : Effects of surgical masks on droplet dispersion under various oxygen delivery modalities. Crit Care 25 : 89, 2021.
PubMed
26) Prakash J, Bhattacharya PK, Yadav AK, et al : ROX index as a good predictor of high fow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta analysis. J Crit Care 66 : 102-108, 2021.
 
27) 倉島一喜 : 各施設の対応 : 埼玉県立循環器呼吸器病センター. 小倉高志 (編): 別冊「呼吸器ジャーナル」COVID-19の病態・診断・治療 現場の知恵とこれからの羅針盤, pp.158-162, 医学書院, 2020.
 
28) Schmidt M, Franchineau G, Combes A : Recent advances in venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Curr Opin Crit Care 25 : 71-76, 2019.
PubMed
29) Combes A, Hajage D, Capellier G, et al : Extra-corporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378 : 1965-1975, 2018.
 
30) Oda T, Hagiwara E, Yamaya T, et al : Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia. Intern Med 61 : 3651-3658, 2022.
PubMed
31) 小倉高志, 岩澤多恵, 泉 信有, 他 : 特集 COVID-19肺炎の画像診断と治療 (2) いかにして重症化を回避するか. 明解 画像診断の手引き : 呼吸器領域編 Suppl 190, pp.1-12, 国際医学出版, 2021.
 
32) 小倉高志, 織田恒幸, 石井 誠, 他 : 発症病態と重症化メカニズム-10のポイント. 呼吸器ジャーナル 新型コロナウイルス感染症 (COVID-19) のすべて, pp.351-361, 医学書院, 2022.
 
33) Nagasawa R, Niwa T, Hagiwara E, et al : Safety and Efficacy of Combination Therapy of Remdesi-vir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Intern Med, 2023. doi: 10.2169/internalmedicine. 0761-22. [Online ahead of print]
 
34) Reddy MP, Subramaniam A, Chua C, et al : Res-piratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med Dec 10 : 1178-1188, 2022.
 
35) Beloncle FM : Is COVID-19 different from other causes of acute respiratory distress syndrome? J Intensive Med 3 : 212-219, 2023.
PubMed
P.975 掲載の参考文献
1) The AASM International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR). American Academy of Sleep Medicine, Illinois, 2023.
 
2) Harper RM, Sauerland EK : The role of the tongue in sleep apnea. In Guilleminault C, Dement WC (eds): Sleep apnea syndrome, Alan R Liss, New York, pp.219-234, 1978.
 
3) Matsumoto T, Murase K, Tabara Y, et al : Impact of sleep characteristics and obesity on diabetes and hypertension across genders and menopausal status; the Nagahama study. Sleep 41, 2018. doi: 10.1093/sleep/zsy071
 
4) 大井元晴, 陳 和夫, 筒井多圭志, 他 : 結核後遺症, 病態生理の立場から (換気). 結核 65 : 847-854, 1990.
 
5) 大井元晴, 平井正志, 山岡新八, 他 : 睡眠時呼吸異常. 日本胸部臨床 43 : 7-14, 1984.
 
6) Berry RB, Quan SF, Abreu AR, et al : The AASM manual for the scoring of sleep and associated events. Rules, terminology and technical specifi-cations, Version 2.6, American Academy of Sleep Medicine, Illinois, 2020
 
7) Masa JF, Kryger MH : Restrictive lung disorders. In Kryger MH, Roth T, Dement WC (eds). Princi-ples and practice of sleep medicine, Fifth Edition, Chapter 112, pp.1308-1317, Saunders, Philadelphia, 2011.
 
8) 日本呼吸器学会NPPVガイドライン作成委員会 (編): NPPV (非侵襲的陽圧換気療法) ガイドライン 改訂第2版. http://fa.jrs.or.jp/guidelines/NPPVGL.pdf
 
9) 日本呼吸器学会 厚生労働科学研究費補助金 難治性疾患政策研究事業「難治性呼吸器疾患・肺高血圧症に関する調査研究」班 (監), 睡眠時無呼吸症候群 (SAS) の診療ガイドライン作成委員会 (編): 睡眠時無呼吸症候群 (SAS) の診療ガイドライン2020. https://minds.jcqhc.or.jp/n/med/4/med0436/G0001211
 
P.982 掲載の参考文献
1) Tarpy SP, Celli BR : Long-term oxygen therapy. N Engl J Med 14 : 710-714, 1995.
 
2) 日本呼吸器学会肺生理専門委員会在宅呼吸ケア白書COPD疾患別解析ワーキンググループ : 在宅呼吸ケア白書2010, 日本呼吸器学会, 東京, 2010.
 
3) Party MRCW : Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale compli-cating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1 : 681-686, 1981.
 
4) Group NOTT : Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 93 : 391-398, 1980.
 
5) 吉良枝郎, 饗庭三代治, 鈴木 勉 : 在宅酸素療法実施症例 (全国) の調査結果について, 厚生省特定疾患呼吸不全調査研究班平成3年度報告書, pp.11-17, 1992.
 
6) Moore RP, Berlowitz DJ, Denehy L, et al : A ran-domised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 66 : 32-37, 2011.
 
7) Long-Term Oxygen Treatment Trial Research Group: A Randomized Trial of Long-Term Oxy-gen for COPD with Moderate Desaturation. N Engl J Med 375 : 1617-1627, 2016.
 
8) Lacasse Y, Casaburi R, Sliwinski P, et al : Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med 10 : 1029-1037, 2022.
PubMed
9) Budhiraja R, Siddiqi TA, Quan SF : Sleep disor-ders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med 11 : 259-270, 2015.
 
10) Fletcher EC, Donner CF, Midgren B, et al : Sur-vival in COPD patients with a daytime PaO2 greater than 60 mm Hg with and without noctur-nal oxyhemoglobin desaturation. Chest 101 : 649-655, 1992.
 
11) Fletcher EC, Luckett RA, Goodnight-White S : A double-blind trial of nocturnal supplemental oxy-gen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis 145 : 1070-1076, 1992.
 
12) Chaouat A, Weitzenblum E, Kessler R et al : A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 14 : 1002-1008. 1999.
 
13) Dean NC, Brown JK, Himelman RB et al : Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 146 : 941-945, 1992.
PubMed
14) O'Donnell DE, Bain DJ, Webb KA : Factors con-tributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 155 : 530-535, 1997.
 
15) Bell EC, Cox NS, Goh N et al: Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev 26 : 160080, 2017.
PubMed
16) Dowman LM, McDonald CF, Bozinovski S et al : Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia. Respirology 22 : 957-964, 2017
PubMed
17) Lacasse Y, Lecours R, Pelletier C et al : Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 25 : 1032-1038, 2005.
PubMed
18) Ekstrom M, Ahmadi Z, Bornefalk-Hermansson A, et al : Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Data-base Syst Rev 11 : CD006429, 2016.
 
19) Visca D, Mori L, Tsipouri V, et al : Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a pro-spective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med 6 : 759-770. 2018
 
20) Carlin BW, Clausen JL, Ries AL : The use of cuta-neous oximetry in the prescription of long-term oxygen therapy. Chest 94 : 239-241, 1988.
 
21) Cullen DL : Long term oxygen therapy adherence and COPD: what we don't know. Chron Respir Dis 3 : 217-222, 2006.
 
22) Katsenos S, Constantopoulos SH : Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance. Pulm Med 2011 : 325362, 2011.
PubMed
23) Gauthier A, Bernard S, Bernard E et al : Adher-ence to long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Chron Respir Dis 16 : 1479972318767724, 2019.
 
24) Bjorklund F, Ekstrom M et al : Adverse Effects, Smoking, Alcohol Consumption, and Quality of Life during Long-Term Oxygen Therapy: A Nationwide Study. Ann Am Thorac Soc 19 : 1677-1686, 2022.
 
P.989 掲載の参考文献
1) Dysart K, Miller TL, Wolfson MR, et al : Research in high flow therapy: mechanisms of action. Respir Med 103 : 1400-1405, 2009.
PubMed
2) Groves N, Tobin A : High flow nasal oxygen generates positive airway pressure in adult vol-unteers. Aust Crit Care 20 : 126-131, 2007.
 
3) American Association for Respiratory Care ; Restrepo RD, Walsh BK : Humidification during invasive and noninvasive mechanical ventilation: 2012. Respir Care 57 : 782-788, 2012.
 
4) Frat JP, Thille AW, Mercat A, et al : High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372 : 2185-2196, 2015.
PubMed
5) Kang BJ, Koh Y, Lim CM, et al : Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 41 : 623-632, 2015.
PubMed
6) 日本呼吸器学会NPPVガイドライン作成委員会 (編): NPPV (非侵襲的陽圧換気療法) ガイドライン改訂第2版, 南江堂, 2015.
 
7) Braunlich J, Seyfarth HJ, Wirtz H : Nasal High-flow versus non-invasive ventilation in stable hypercapnic COPD: a preliminary report. Multi-disciplinary respiratory medicine 10 : 27, 2015.
 
8) Storgaard LH, Hockey HU, Laursen BS, et al : Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 13 : 1195-1205, 2018.
PubMed
9) Nagata K, Kikuchi T, Horie T, et al : Domicili-ary High-Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover Trial. Ann Am Thorac Soc 15 : 432-439, 2018.
 
10) Nagata K, Horie T, Chohnabayashi N, et al : Home high-flow nasal cannula oxygen therapy for sta-ble hypercapnic COPD: a randomized trial. Am J Respir Crit Care Med 206 : 1326-1335, 2022.
 
P.996 掲載の参考文献
1) Le Pimpec-Barthes F, Legras A, Arame A, et al : Diaphragm pacing: the state of the art. J Thorac Dis 8 : S376-386, 2016.
 
2) Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, et al : An official ATS clinical policy statement: Congenital central hypoventilation syndrome Genetic basis, diagnosis, and management. Am J Respir Crit Care Med 181 : 626, 2010.
 
3) Clinicaltrials. gov: Electrical Activation of The Diaphragm for Ventilatory Assist. https://www.clinicaltrials.gov/ct2/show/results/NCT00010374?term+AD0-diaphragm+-pacing+ACY-draw+AD0-2+ACY-rank+AD0-20
 
4) Posluszny JA, Onders R, Kerwin AJ, et al : Multi-center review of diaphragm pacing in spinal cord injury: successful not only in weaning from ventila-tors but also in bridging to independent respiration. J Trauma Acute Care Surg 76 : 303, 2014.
 
5) Onders RP, Elmo M, Kaplan C, et al : Long-term experience with diaphragm pacing for traumatic spinal cord injury: Early implantation should be considered. Surgery 164 : 705, 2018.
PubMed
6) Yokota K, Masuda M, Koga R, et al : Diaphragm pacing implantation in Japan for a patient with cervical spinal cord injury: A case report. Medicine (Baltimore) 101: e29719, 2022.
PubMed
7) Yamada Y, Hasegawa H, Ochi T, et al : Diaphragm pacing for congenital central hypoventilation syn-drome: A novel case of pacing implanted into the diaphragm. Pediatr Int 64 : e14915, 2022.
 

【Diagnosis】

P.1005 掲載の参考文献
1) Kino T, et al : FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological char-acteristics. J Antibiot 40 : 1249-1255, 1987.
 
2) Kino T, et al : FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40 : 1256-1265, 1987.
PubMed
3) 増田智先 : 最新の知見・臨床での実際 タクロリムス. 薬事 54 : 951-955, 2012.
 
4) 免疫抑制薬 TDM 標準化ガイドライン2018 [臓器移植編] 2018.
 
5) 岩崎一秀 : タクロリムスの人における体内動態. 今日の移植 12 : 11-18, 1999.
 
6) 北原隆志, 他 : タクロリムス血中濃度測定機器の比較検討. 医療薬学 35 : 453-457, 2009.
Medical*Online
7) 土筆智晶, 他 : Dimensionタクロリムス試薬 (TAC) の改善点および新たな注意点-低濃度域における精密性とEDTAの影響-. 医学検査 66 : 242-247, 2017.
Medical*Online
8) P. E. Wallemacq, V. Furlan, A. Moller, et al : Pharmacokinetics of tacrolimus (FK 506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet 23 : 367-370, 1998.
 

書評

最近チェックした商品履歴

Loading...